Vol 25, No 6 (2020)
Reviews
Published online: 2020-11-01
Approach to radiation therapy in the Jehovah’s Witness patient: An overview
DOI: 10.1016/j.rpor.2020.08.014
Rep Pract Oncol Radiother 2020;25(6):856-859.
Abstract
Jehovah’s Witnesses are well-known in the medical community for their inability to accept blood products. Novel methods of treatment are often needed to avoid anemia and hematologic toxicity as inability to receive blood products may increase the risk of treatment related complications. We provide an overview of radiation treatment for Jehovah’s Witness patients with an emphasis on bone marrow sparing strategies with intensity modulated radiation therapy (IMRT) to minimize hematologic toxicity.
Keywords: Jehovah witnessRadiation oncologyAnemiaHematologic toxicityBone marrow sparingBMS-IMRT